Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

General Mills Looks Alluring On Savings & Other Growth Plans

Published 03/04/2019, 11:57 PM
Updated 07/09/2023, 06:31 AM

Despite rising costs General Mills, Inc. (NYSE:GIS) is among the few food companies that are depicting robust performance on efforts to boost sales and generate higher savings. Well, such aspects are fueling investors’ optimism in the stock that has gained almost 17.6% in the past three months, against the industry’s decline of 6.3%. Let’s take a closer look at the factors aiding this Zacks Rank #2 (Buy) stock.

Consumer First Strategy & Benefits From Buyouts

General Mills is on track with the Consumer First strategy as well as key global growth strategies to boost sales. To this end, the company is focused on innovations, efficient customer marketing and strong in-store execution to sharpen competitive edge. The company’s next main strategy is to focus on driving growth across four differential global platforms — Haagen-Dazs ice cream, snack bars, Old El Paso Mexican food as well as General Mills’ natural and organic food brands.

Finally, the company is working toward reshaping its portfolio via prudent buyouts and divestitures. In connection with this, General Mills acquired Blue Buffalo Pet Products in April 2018 and is on track to integrate the same. We note that Blue Buffalo has emerged as one of the leading brands in the pet food category and is aiding revenue growth. The company continues to envision growth in this business in the forthcoming periods. Moreover, management plans expanding the Blue Buffalo product line in categories such as Drug, Food and mass channels. Apart from these, the company is focused on improving e-commerce channel considering its acceleration.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Prudent Cost Saving Strategies

General Mills is currently pursuing several initiatives to improve operational efficiency and generate cost savings. It expects to achieve cost savings through SKU optimization, supply chain optimization and continued expansion of zero-based budgeting across the business. These factors are expected to accelerate the company’s margins.

Further, the company is on track with the Holistic Margin Management (HMM) plan that is expected to generate greater savings this year. In fact, savings from this initiative aided margin expansions during the second quarter of fiscal 2019. Previously, management had stated that it expects cost of goods HMM savings of roughly $450 million in fiscal 2019. Notably, this will exceed the company’s year-ago savings and will be backed by global sourcing initiatives.

Wrapping Up

Together, these efforts are likely to continue providing cushion to the company from input cost inflation and costs related to growth investments in fiscal 2019. Moreover, the company’s dedicated focus on customer-led innovation and marketing are encouraging. All said, we expect this renowned food company to sustain in investors good books.

Greedy for Consumer Staples Stocks? Check These

The Estee Lauder Companies (NYSE:EL) has long-term earnings per share (EPS) growth rate of 12.4% and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Philip Morris International (NYSE:PM) has a long-term EPS growth rate of 9% and currently carries a Zacks Rank #2.

Lamb Weston Holdings (NYSE:LW) has a long-term EPS growth rate of 12% and holds a Zacks Rank #2 at present.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Lamb Weston Holdings Inc. (LW): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

Philip Morris International Inc. (PM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.